PMV Capital Advisers’s Novo Nordisk NVO Stock Holding History

PMV Capital Advisers’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262K	Buy	5,464 +177	+3%	+$7.61K	0.39%	25
2026 Q1	$194K	Sell	5,287 -14	-0.3%	-$663	0.33%	27
2025 Q4	$270K	Hold	5,301	–	–	0.49%	24
2025 Q3	$294K	Hold	5,301	–	–	0.57%	23
2025 Q2	$366K	Hold	5,301	–	–	0.82%	21
2025 Q1	$368K	Buy	5,301 +9	+0.2%	+$743	0.89%	21
2024 Q4	$455K	Buy	+5,292	New	+$572K	1.23%	14

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

PMV Capital Advisers's NVO Position: Q2 2026 in Review

PMV Capital Advisers increased its Novo Nordisk (NVO) stake by 3.3% in Q2 2026, buying an estimated $7.61K and bringing the position to 5,464 shares worth $262K. The position accounts for 0.39% of the portfolio, ranked #25.

PMV Capital Advisers first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $455K in Q4 2024. 1,354 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

PMV Capital Advisers held 5,464 shares of Novo Nordisk worth $262K as of Q2 2026.
PMV Capital Advisers bought 177 Novo Nordisk shares in Q2 2026, an estimated $7.61K.
Novo Nordisk made up 0.39% of PMV Capital Advisers's portfolio in Q2 2026, its #25 holding.
PMV Capital Advisers first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
PMV Capital Advisers's Novo Nordisk position peaked at $455K in Q4 2024.
1,354 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on PMV Capital Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.